Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03718637 · ClinicalTrials.gov registry record · Phase 4
Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)
A Phase 4 study of Lateral Epicondylitis and Tennis Elbow, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03718637 is a Phase 4 study of Lateral Epicondylitis and Tennis Elbow that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 40 participants, below the 122-participant average among 7 other Lateral Epicondylitis trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03718637, a Phase 4 study of Lateral Epicondylitis and Tennis Elbow, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are testing the efficacy of a new, FDA-approved bioinductive patch in lateral epicondylitis (tennis elbow) patients. A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomize into one of two groups: control and investigational. Patients in the "control group" will receive the normal surgery for patients who do not respond to physical therapy, lifestyle changes, and anti-inflammatory treatment. Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.
Conditions Studied
Interventions
- BIOLOGICAL Smith & Nephew Bioinductive Implant
- PROCEDURE Lateral Epicondylectomy
- RADIATION Ultrasound Imaging
Study Locations (1)
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-04-17 |
| Est. Completion | 2027-01-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03718637
The ClinicalTrials.gov registry entry for NCT03718637 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 122-participant average among 7 other Lateral Epicondylitis trials with a reported enrollment target (67% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lateral Epicondylitis appearing as the primary indexed condition, and to 3 interventions - of which Smith & Nephew Bioinductive Implant is the first listed.
NCT03718637 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03718637 about?
NCT03718637 is a clinical study titled "Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)". The investigators are testing the efficacy of a new, FDA-approved bioinductive patch in lateral epicondylitis (tennis elbow) patients. A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomize into one of two groups: control and inve...
What is the current status of trial NCT03718637?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2019-04-17. Estimated completion is 2027-01-17.
What conditions does trial NCT03718637 study?
This clinical trial studies the following conditions: Lateral Epicondylitis, Tennis Elbow.
What interventions are being tested in trial NCT03718637?
The interventions under investigation include: Smith & Nephew Bioinductive Implant (BIOLOGICAL), Lateral Epicondylectomy (PROCEDURE), Ultrasound Imaging (RADIATION).
Who is sponsoring clinical trial NCT03718637?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03718637 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lateral Epicondylitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Blood Flow Restriction & Tennis Elbow Rehab
RECRUITING · NA
-
Trial of Blood Flow Restriction Plus Physical Therapy vs. Physical Therapy Alone for Lateral Epicondylitis
ACTIVE NOT RECRUITING · NA
-
Doxycycline for Elbow Tendinopathy
ACTIVE NOT RECRUITING · Phase 1
-
Randomized Trial of Iontophoresis Versus Injection of Corticosteroids for Lateral Epicondylitis
COMPLETED · Phase 3
-
Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis
COMPLETED · Phase 2
-
Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.